Whistleblower - Revision history

Mhurlocker at 19:04, September 21, 2026

2026-09-21T19:04:47Z

← Older revision		Revision as of 13:04, September 21, 2026
Line 24:		Line 24:
	Policy No.: '''8018'''<br />		Policy No.: '''8018'''<br />
	Effective Date: '''04/11/19'''<br />		Effective Date: '''04/11/19'''<br />
	Revised Date: '''04/11/19''' <br />		Revised Date: '''09/17/26'''<br />
	Reviewed Date: '''07/09/24'''<br />		Reviewed Date: '''09/17/26'''<br />
	<br />		<br />
	<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation		<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation

Mhurlocker at 19:03, September 21, 2026

2026-09-21T19:03:04Z

← Older revision		Revision as of 13:03, September 21, 2026
Line 51:		Line 51:
	Additionally, employees of contractors, grantees, subcontractors, and subgrantees, when working on Federal grants and contracts in connection with the University of Nebraska, have certain whistleblower rights and remedies afforded by statute, including but not limited to 41 U.S.C. § 4712 (Enhancement of Contractor Protection from Reprisal for Disclosure of Certain Information). Accordingly, all such contractors, grantees, subcontractors, and subgrantees are required to comply with all applicable laws.		Additionally, employees of contractors, grantees, subcontractors, and subgrantees, when working on Federal grants and contracts in connection with the University of Nebraska, have certain whistleblower rights and remedies afforded by statute, including but not limited to 41 U.S.C. § 4712 (Enhancement of Contractor Protection from Reprisal for Disclosure of Certain Information). Accordingly, all such contractors, grantees, subcontractors, and subgrantees are required to comply with all applicable laws.
	==Additional Information==		==Additional Information==
	*[mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer], 402-559-9576
	*UNMC Compliance Office, 402-559-6767		* [mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer], 402-559-9576
	*UNMC Ombuds Team Referral Office, 402-559-2491		* UNMC Compliance Office, 402-559-6767
	*[http://nebraskalegislature.gov/divisions/ombud.php The State Ombudsman's Office]		* UNMC Ombuds Team Referral Office, 402-559-2491
	*University of Nebraska: Reporting Fraud:		* [http://nebraskalegislature.gov/divisions/ombud.php The State Ombudsman's Office]
	:*[https://secure.ethicspoint.com/domain/media/en/gui/52126/index.html NU EthicsPoint - Reporting Fraud]		* University of Nebraska: Reporting Fraud: [https://secure.ethicspoint.com/domain/media/en/gui/52126/index.html NU EthicsPoint - Reporting Fraud]
	*Nebraska State Government Effectiveness Act:
	:*http://nebraskalegislature.gov/divisions/ombud-whistle.php		* Nebraska State Government Effectiveness Act:
	:*http://nebraskalegislature.gov/pdf/ombudsman/lb475_rights.pdf
			* http://nebraskalegislature.gov/divisions/ombud-whistle.php
			* http://nebraskalegislature.gov/pdf/ombudsman/lb475_rights.pdf
			* [https://wiki.unmc.edu/index.php?title=Non-Discrimination_and_Harassment&mobileaction=toggle_view_desktop UNMC Policy 1099, Non-Discrimination and Harassment]

			----[SW1]Added text and link


	This page maintained by [mailto:mhurlocker@unmc.edu mh].		This page maintained by [mailto:mhurlocker@unmc.edu mh].

Mhurlocker at 15:58, March 7, 2025

2025-03-07T15:58:27Z

← Older revision		Revision as of 09:58, March 7, 2025
Line 20:		Line 20:
	</table>		</table>
	<br />		<br />
	[[Compliance Program]] \| [[Compliance Hotline]] \| [[Inspections/Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]] \| [[Electronic Digital Signatures and Records]] \| [[Utilizing Generative AI]]<br />		[[Compliance Program]] \| [[Compliance Hotline]] \| [[Inspections/Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]] \| [[Electronic Digital Signatures and Records]] \| [[Utilizing Generative AI\|UNMC AI Use Guidelines]]<br />
	<br />		<br />
	Policy No.: '''8018'''<br />		Policy No.: '''8018'''<br />

Mhurlocker at 19:49, March 6, 2025

2025-03-06T19:49:45Z

← Older revision		Revision as of 13:49, March 6, 2025
Line 20:		Line 20:
	</table>		</table>
	<br />		<br />
	[[Compliance Program]] \| [[Compliance Hotline]] \| [[Inspections/Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]] \| [[Electronic Digital Signatures and Records]]<br />		[[Compliance Program]] \| [[Compliance Hotline]] \| [[Inspections/Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]] \| [[Electronic Digital Signatures and Records]] \| [[Utilizing Generative AI]]<br />
	<br />		<br />
	Policy No.: '''8018'''<br />		Policy No.: '''8018'''<br />

Mhurlocker: /* Additional Information */

2024-08-19T19:52:38Z

Additional Information

← Older revision		Revision as of 13:52, August 19, 2024
Line 62:		Line 62:


	This page maintained by [mailto:~~dpanowic~~@unmc.edu ~~dkp~~].		This page maintained by [mailto:mhurlocker@unmc.edu mh].

Mhurlocker at 14:02, July 11, 2024

2024-07-11T14:02:05Z

← Older revision		Revision as of 08:02, July 11, 2024
Line 25:		Line 25:
	Effective Date: '''04/11/19'''<br />		Effective Date: '''04/11/19'''<br />
	Revised Date: '''04/11/19''' <br />		Revised Date: '''04/11/19''' <br />
	Reviewed Date: '''07/21/23'''<br />		Reviewed Date: '''07/09/24'''<br />
	<br />		<br />
	<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation		<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation

Mhurlocker at 14:13, August 14, 2023

2023-08-14T14:13:15Z

← Older revision		Revision as of 08:13, August 14, 2023
Line 20:		Line 20:
	</table>		</table>
	<br />		<br />
	[[Compliance Program]] \| [[Compliance Hotline]] \| [[Inspections/Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]]<br />		[[Compliance Program]] \| [[Compliance Hotline]] \| [[Inspections/Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]] \| [[Electronic Digital Signatures and Records]]<br />
	<br />		<br />
	Policy No.: '''8018'''<br />		Policy No.: '''8018'''<br />

Mhurlocker at 20:39, August 7, 2023

2023-08-07T20:39:24Z

← Older revision		Revision as of 14:39, August 7, 2023
Line 25:		Line 25:
	Effective Date: '''04/11/19'''<br />		Effective Date: '''04/11/19'''<br />
	Revised Date: '''04/11/19''' <br />		Revised Date: '''04/11/19''' <br />
	Reviewed Date:07/21/23<br />		Reviewed Date: '''07/21/23'''<br />
	<br />		<br />
	<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation		<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation

Mhurlocker: updated review date, no edits

2023-07-21T20:04:25Z

updated review date, no edits

← Older revision		Revision as of 14:04, July 21, 2023
Line 25:		Line 25:
	Effective Date: '''04/11/19'''<br />		Effective Date: '''04/11/19'''<br />
	Revised Date: '''04/11/19''' <br />		Revised Date: '''04/11/19''' <br />
	Reviewed Date: ~~'''11~~/19/~~21'''~~ <br />		Reviewed Date:07/21/23<br />
	<br />		<br />
	<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation		<big>'''Reporting Suspected University-Related Misconduct and Prohibition Against Retaliation
	(Whistleblower Policy)~~'''~~</big>		(Whistleblower Policy)</big>
	==Basis for Policy==		==Basis for Policy==
	The general purpose of this policy is to protect any University of Nebraska Medical Center (UNMC) student, employee or other member of the University community (hereinafter "Individuals") who makes a good-faith disclosure of suspected University-related misconduct. This policy supplements the existing Nebraska whistleblower law, the Nebraska State Effectiveness Act, Neb. Rev. Stat. § 81-2701 to § 81-2711, which protects state employees who report wrongdoing to elected State officials. (University of Nebraska Board of Regents Minutes, 75, January 25, 2019, pp. 95 and 101-102)		The general purpose of this policy is to protect any University of Nebraska Medical Center (UNMC) student, employee or other member of the University community (hereinafter "Individuals") who makes a good-faith disclosure of suspected University-related misconduct. This policy supplements the existing Nebraska whistleblower law, the Nebraska State Effectiveness Act, Neb. Rev. Stat. § 81-2701 to § 81-2711, which protects state employees who report wrongdoing to elected State officials. (University of Nebraska Board of Regents Minutes, 75, January 25, 2019, pp. 95 and 101-102)

Dpanowic at 16:30, November 10, 2022

2022-11-10T16:30:42Z

← Older revision		Revision as of 10:30, November 10, 2022
Line 20:		Line 20:
	</table>		</table>
	<br />		<br />
	[[Compliance Program]] \| [[Compliance Hotline]] \| [[Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]]<br />		[[Compliance Program]] \| [[Compliance Hotline]] \| [[Inspections/Investigations by Third Parties]] \| [[Research Integrity]] \| [[Export Control]] \| [[Code of Conduct]] \| [[Use of Human Anatomical Material]] \| [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] \| [[Contracts]] \| [[Conflict of Interest]] \| [[Red Flag Identity Theft Prevention Program]] \| [[Principles of Financial Stewardship]] \| [[Human Tissue Use and Transfer]] \| [[Disclosing Foreign Support and International Activities]] \| [[Health Care Vendor Interactions]] \| [[Credit Hour Definition]] \| [[Whistleblower]]<br />
	<br />		<br />
	Policy No.: '''8018'''<br />		Policy No.: '''8018'''<br />